Gum disease

Independent professional body guideline

BSPID gum disease and diabetes guideline

2021-06-25T08:04:00+01:00By British Society of Periodontology and Implant Dentistry

A short overview of periodontal (gum disease) and its links with diabetes, including advice for community pharmacy teams

20210603 Guidelines comparison table [online]

Independent professional body guideline

Type 2 diabetes pharmacological management pathway comparison

2021-06-04T09:40:00+01:00By Guidelines team

This comparison table summarises recommendations on the management of hyperglycaemia in adults with type 2 diabetes from ADA/EASD, NICE, and SIGN

Measuring blood sugar on finger_AS

NICE guideline

NICE type 2 diabetes guideline

2020-12-17T00:00:00+00:00By

This summary provides recommendations on blood glucose targets, patient education, and includes a useful algorithm on blood glucose management

Doctor talking to male patient in office

Working party guideline/algorithm

Guideline for the managed introduction of biosimilar basal insulin

2019-10-09T15:02:00+01:00By Working party—Down Beba Brown Diggle Goel Milne

This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Mylan.

diabetes equipment 640x426

SIGN guideline

SIGN type 2 diabetes guideline

2018-01-16T11:53:00+00:00By

This summary provides key recommendations on lifestyle management, treatment options, diabetic CVD, and CKD. Includes a useful treatment algorithm

Resource hub

  • Blood glucose diaries

Educational resources

A nurse consulting with a woman in WPG Yellow

Guideline for the managed introduction of biosimilar bolus insulin in individuals with type 2 diabetes

By Working party–Down Beba Davies Diggle Goel

This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Sanofi Ltd.

Final version - GLN supplement (print version)

Dipeptidyl peptidase-4 inhibitors—still a major player in type 2 diabetes care

Commissioned by Boehringer Ingelheim Limited

This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines.
View Trajenta® (linagliptin) prescribing and adverse event reporting information
PC-GB-103452 Date of preparation: January 2021

Final version - G4N supplement (print version)

Dipeptidyl peptidase-4 inhibitors—still a major player in type 2 diabetes care

Commissioned by Boehringer Ingelheim Limited

This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines for Nurses.
View Trajenta® (linagliptin) prescribing and adverse event reporting information
PC-GB-103453  Date of preparation: January 2021

doctor & older man 1 260x173

Diabetes and frailty: guidance on the management of older adults with type 2 diabetes

By Strain Down Brown Puttanna and Sinclair

Information intended for UK healthcare professionals only. This summary was developed by Guidelines and Dr Strain, based on the guidance developed by Strain WD et al., with the support of a sponsorship from Novo Nordisk UK.

Su Down video image

Identification of pancreatic exocrine insufficiency (PEI) in patients with diabetes

Commissioned by Viatris

In this video, Su Down looks at the identification of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.

NON-2020-3287 December 2020